Key facts
- Wellola’s last known valuation is $6.0M.
- It has raised $4.0M; the latest was Later Stage VC ($2.4M) in Aug 2024.
- Notable investors include Enterprise Ireland, Elkstone, Adopt A Startup, Bay Advisory, Business Venture Partners — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Wellola
- ·The full record, as it builds
Funding rounds
No funding rounds for Wellola are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Wellola
Developer of a healthcare software designed to offer a modularised and interoperable platform that gives patients access to their medical information. The company's platform integrates or plugs into private practice systems to offer a wide range of services like video consultations, secure messaging, form completion, symptom tracking, and remote monitoring, enabling hospitals to reduce the cost of care and treat patients through a single platform.
- Sector
- Healthcare
- HQ
- Leeds, United Kingdom
- Founded
- 2016
- Employees
- 11
- Website
- wellola.com/
- Ownership
- Privately Held (backing)
Wellola doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Wellola shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Wellola in its N-PORT filings yet. We sweep new filings monthly.